Cardiovascular Disease Doctors in Harvey, IL Accepting Medicare

5 Cardiovascular Disease doctors found. Showing 1 - 5

Sushil A Sheth, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1 Ingalls Dr, Harvey, IL 60426 Phone: 630-321-0097    Fax: 630-321-0909

Dr. Ripple Rajesh Doshi, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 71 W 156th St Ste 305, Harvey, IL 60426 Phone: 708-331-2200    Fax: 708-331-8015

Dr. Andy C Lin, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 71 W 156th St, Suite 305, Harvey, IL 60426 Phone: 708-331-2200    Fax: 708-331-8015

Ponnambalam S Sundram, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 71 W 156th St, Ste 305, Harvey, IL 60426 Phone: 708-331-2200    Fax: 708-331-8015

Francis Q Almeda, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 71 W 156th St, Harvey, IL 60426 Phone: 708-331-2200    Fax: 708-331-8015

News Archive

Adalimumab and methotrexate is about five times more effective than methotrexate alone for rheumatoid arthritis

For people with long-standing rheumatoid arthritis, combined treatment with the new "biologic" drug adalimumab and methotrexate is about five times more effective than methotrexate alone, according to a new systematic review of studies.

Research shows exposure to BPA may play a role in unexplained infertility

As many as 20 percent of infertile couples in the United States have unexplained reasons for their infertility. Now, new research led by Catherine Racowsky, PhD, director of the Assisted Reproductive Technologies Laboratory at Brigham and Women's Hospital (BWH), shows that exposure to BPA (Bisphenol-A) could be a contributing factor as to why some infertile couples are having difficulty conceiving.

Study could lead to the development of novel treatments for drug-resistant cancers

ETC-159, a made-in-Singapore anti-cancer drug that is currently in early phase clinical trials for use in a subset of colorectal and gynecological cancers, could also prevent some tumors from resisting therapies by blocking a key DNA repair mechanism, researchers from Duke-NUS Medical School and the Agency for Science, Technology and Research in Singapore reported in the journal EMBO Molecular Medicine.

Labor chief asks for probe into health insurance lobbying

The Wall Street Journal/Dow Jones reports: "AFL-CIO President Richard Trumka on Thursday urged some state insurance commissioners to investigate how the costs of insurers' lobbying to defeat health-insurance reform are affecting premiums."

Read more Medical News

› Verified 2 days ago